TG Therapeutics Depreciation & Amortization 2011-2026 | TGTX

Annual Depreciation & Amortization TG Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
68 K	211 K	303 K	282 K	158 K	100 K	88 K	82 K	63 K	15.5 K	3.93 K	1.13 K	235	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
303 K	235	106 K

Quarterly Depreciation & Amortization TG Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	8 K	-	-	-	29 K	-	-	-	68 K	-	230 K	154 K	76 K	-	202 K	126 K	59 K	-	105 K	64 K	30 K	-	72 K	46 K	23 K	-	64 K	41 K	20 K	-	62 K	41 K	20 K	-	42.5 K	23.3 K	6.38 K	-	10.3 K	5.8 K	2.42 K	-	2.45 K	1.56 K	706	-	634	309	115	-	118	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
230 K	115	48.1 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Adagene ADAG	723 K	$ 1.9	-3.11 %	$ 107 M	China
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	28.2 M	$ 25.87	-0.79 %	$ 1.25 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.71	1.88 %	$ 17 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	22.2 M	$ 64.74	1.41 %	$ 8.66 B	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 3.96	-1.0 %	$ 8.62 B	Israel
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Biogen BIIB	673 M	$ 164.87	0.27 %	$ 24 B	USA
Bio-Path Holdings BPTH	82 K	-	-	$ 100 K	USA
BioVie BIVI	229 K	$ 1.23	2.07 %	$ 1.82 M	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA